| Bioactivity | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine |
| CAS | 2072145-54-9 |
| Formula | C32H27NO9 |
| Molar Mass | 569.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine
CAS: 2072145-54-9 F: C32H27NO9 W: 569.56
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine is a purine nucleoside analog. Purine nucleoside analogs have b
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.